SEC Filing Summary: SIGA Technologies, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by SIGA Technologies, Inc. on October 5, 2016, reporting events occurring on that date. The filing addresses the company's ongoing obligations related to a judgment owed to PharmAthene, Inc. arising from prior bankruptcy proceedings.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or margin data. The specific financial event reported is a cash outflow of $100 million paid to PharmAthene, Inc. on October 5, 2016. This payment was a condition precedent to extending the deadline for satisfying the remainder of the PharmAthene Judgment.
Material Changes
- Payment Execution: SIGA completed the required $100 million payment to PharmAthene on October 5, 2016.
- Deadline Extension: As a result of the payment, the deadline to satisfy the remaining balance of the PharmAthene Judgment was extended from October 19, 2016, to November 30, 2016.
Outlook, Risks, and Contingencies
The primary contingency noted is the remaining balance of the PharmAthene Judgment, which must be satisfied by the new deadline of November 30, 2016. The filing confirms that the condition for this extension has been met. No forward-looking guidance regarding revenue or operational outlook is provided in this specific report.
Investor Verification Checklist
- Verify the total outstanding balance of the PharmAthene Judgment remaining after the $100 million payment.
- Confirm SIGA's current cash and liquidity position to ensure the ability to meet the November 30, 2016, payment deadline.
- Review the original Third Amended Chapter 11 Plan to understand the full scope of the judgment and any other potential obligations.